Publications by authors named "Ursula Karnthaler"
Article Synopsis
- The study evaluates the real-world effectiveness of two oral antivirals, nirmatrelvir-ritonavir and molnupiravir, against the Omicron variant of SARS-CoV-2 in non-hospitalized adults.
- Data were obtained from a retrospective cohort study involving over 113,000 confirmed cases of Covid-19, comparing treated patients with untreated controls to assess risks of hospitalization and death within 28 days.
- Results showed that nirmatrelvir-ritonavir significantly reduced hospitalization and death rates, especially in individuals aged 60 and older; however, molnupiravir did not show a significant difference in these outcomes compared to untreated controls.
Currently countries across the globe are preparing for the fourth wave of SARS-CoV-2 infections, which is mainly driven by the rapid spread of novel SARS-CoV-2 variants. Austria and, in particular, the capital city of Vienna, witnessed a disproportionally steep rise in SARS-CoV-2 infection rates during the last wave of infections. By the end of January 2021, the government of Vienna launched an innovative, state-wide SARS-CoV-2 screening program based on PCR analysis of self-collected mouthwash samples.
View Article and Find Full Text PDFWe report on an outbreak caused by Salmonella enteritidis phage type 4 (PT4) among 143 participants at a soccer camp in Austria in August 2010. The outbreak affected 34 persons, including 24 epidemiologically related cases and 10 laboratory-confirmed cases. Food-specific cohort analyses revealed spaetzle (homemade noodles) (relative risks (RR): 2.
View Article and Find Full Text PDF